Target Audience:

  • Pharmacy
  • Chronic Pain Clinic
  • Emergency Medicine/Urgent Care
  • Hospital Medicine
  • Neurology
  • All Departments of Medicine/Family practice (MDs, RNs, NPs, & PharmDs)
    • Adult PrimaryCare
    • Family Medicine
    • Occupational Health
    • Medicine Sub-Specialties (Cardio,Gastroenterology, Nephrology, Oncology, Pulmonology, Orthopedics, Neurology)
    • Surgical Sub-Specialties (Anesthesia, Peri-op Medicine (POM), Interventional Radiology and Pain)

Lunch will be provided for the first 120 people who stay for the entire event. 

Microsoft TEAMS: Click "Take Course" and the link will be available in the course instructions. 


  • Shirley Ng, PharmD, Post-Graduate Year 1 Pharmacist Resident, Kaiser Permanente, San Jose 
  • Eric Arevalo, MD, Post-Graduate Year 1 Psychiatry Resident, Kaiser Permanente, San Jose
  • Mia Zaharna, Sleep Medicine Physician, Kaiser Permanente, San Jose  


  • Patrice Lucas, PharmD, BCPS; CME Committee Member, CME Planner (P&T), Drug Education Coordinator; Kaiser Permanente, San Jose
  • Lily Nguyen, PharmD, BCPS; Clinical Operations Manager; Kaiser Permanente, San Jose
  • Erica Chen, PharmD, BCPS, CDE, PGY1 Residency Program Coordinator, Kaiser Permanente, San Jose 
  • Stefany Shimada, PharmD, BCPS, CDE, Drug Education Coordinator, Kaiser Permanente, San Jose
  • Haritha Rachamallu, MD, Kaiser Permanente, San Jose

Session Objectives:

1. Navigate resources that can be provided to all patients with chronic insomnia, and the process of referring them to available classes when appropriate.
2. Select safe and appropriate therapeutic regimens for all patients with chronic insomnia, including special patient populations.


Chronic insomnia is a rising public health concern affecting the quality of life of nearly one-third of the U.S. population. Clinicians must determine safe and effective treatment options, as well as address underlying causes and tailor therapeutic regimens for special populations. Kaiser Permanente San Jose and Santa Clara offer a wealth of patient resources, including Cognitive Behavioral Therapy for Insomnia (CBT-I) classes, that are highly effective but may be underutilized.. Although insomnia can affect any age group, older adults are disproportionately affected and also at higher risk for medication-related adverse events. The majority of elderly patients in San Jose Medical Center who are on multiple CNSactive medications are on a benzodiazepine (BZD) or non-benzodiazepine sedative/hypnotic (“z-drugs”), agents often used for insomnia. Multiple studies of older adults have reported that the use of CNS-active medications is linked to an increase risk of fractures, falls, and recurrent falls. Deprescribing medications like BZD and “z-drugs” may be a challenging undertaking but can achieved successfully using a tailored, gradual taper incorporating strategies to minimize discontinuation symptoms and alternative options.


The speaker(s) and planning committee have no financial relationships to disclose.

Credit Statement:

**Kaiser Permanente San Jose Medical Center is accredited by the California Medical Association (CMA) to provide continuing medical education for physicians.
Kaiser Permanente San Jose takes responsibility for the content, quality and scientific integrity of this CME activity.
**Kaiser Permanente San Jose Medical Center designates this Live Course for a maximum of 1.0 AMA PRA Category 1 Credit™
Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Session date: 
Wednesday, February 5, 2020 - 12:30pm to 1:30pm
  • 1.00 AMA PRA Category 1 Credit(s)™
  • 1.00 Geriatrics

Please login or register to take this course.
CME Office: 
San Jose Medical Center
Conference room: 
Building 6, Lobby Level, Rooms 1-4